Clinical Trial Update: Reducing Reconsolidation of Trauma Memories With Propranolol [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether propranolol can reduce reconsolidation of trauma memories in PTSD. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Douglas Mental Health University Institute | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: UNKNOWN